Lovastatin Inhibits RhoA to Suppress Canonical Wnt/β-Catenin Signaling and Alternative Wnt-YAP/TAZ Signaling in Colon Cancer.
Statins are first-line drugs used to control patient lipid levels, but there is recent evidence that statin treatment can lower colorectal cancer (CRC) incidence by 50% and prolong CRC patient survival through mechanisms that are poorly understood. In this study, we found that the treatment of APC
Published In/Presented At
Xiao, Y., Liu, Q., Peng, N., Li, Y., Qiu, D., Yang, T., Kang, R., Usmani, A., Amadasu, E., Borlongan, C. V., & Yu, G. (2022). Lovastatin Inhibits RhoA to Suppress Canonical Wnt/β-Catenin Signaling and Alternative Wnt-YAP/TAZ Signaling in Colon Cancer. Cell transplantation, 31, 9636897221075749. https://doi.org/10.1177/09636897221075749
Medical Education | Medicine and Health Sciences
USF-LVHN SELECT Program, USF-LVHN SELECT Program Students